University of Tokyo and Keio University joined multiple corporates in a round that brought the pre-clinical drug developer's funding haul to $33.1m.

The Harvard motor neurone disease drug developer secured the return of Amgen Ventures for its series A round.

The Johns Hopkins University-founded wound evaluation software developer had counted Tencent and Penn Medicine among its backers.

A host of corporate investors including BIVF, Axa Venture Partners and New York Life Ventures invested to bring prescription adherence app developer Wellth's total to $17.1m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Baidu Ventures portfolio company Qitan Technology has pulled in $14.1m to progress its pathogen detection technology for drug development and diagnostics.

Dexcel Pharma formed part of a consortium that has supplied $80.5m in series A financing to Kriya Therapeutics, a gene therapy developer exploiting Stanford University research.

Dexcel Pharma formed part of a consortium that has supplied $80.5m in series A financing to Kriya Therapeutics, a gene therapy developer exploiting Stanford University research.

6 Dimensions Capital led a round for mental health treatment portal Haoxinqing that will go to expanding the latter's R&D and partnership activities.

Biopharmaceutical firm Jubilant Life Sciences has licensed molecules with potential to fight cancer to a new venture formed with Frazier Healthcare Partners.